The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Allarity Therapeutics signs first commercial contract for CLIA laboratory services

Oct 30, 2026 11:45 (3h ago)

Verifying

Allarity Therapeutics signed its first commercial agreement under its CLIA-certified laboratory services strategy.
The contract supports a European biotechnology company’s precision oncology device intended for U.S. use.
Allarity received CLIA certification for its Hørsholm laboratory in July 2026.